✦ LIBER ✦

Prescribing policy with dementia drugs: The UK NICE experience

✍ Scribed by Tom Dening

Book ID: 116731982
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 109 KB
Volume: 64
Category: Article
ISSN: 0378-5122
DOI: 10.1016/j.maturitas.2009.08.014

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.3.069 How has NICE guidance affected p

P.3.069 How has NICE guidance affected prescribing in depot clinic schizophrenia outpatients - the dewsbury UK experience

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 252 KB

2286 – The difficulty of diagnosing deme

2286 – The difficulty of diagnosing dementia in patients with intellectual disability: experience from a UK memory clinic

✍ Sommerlad, A.; Dudley, A. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 French ⚖ 29 KB

Do caregivers' experiences correspond wi

Do caregivers' experiences correspond with the concerns raised in the literature? Ethical issues relating to anti-dementia drugs

✍ Anna R. Huizing; Ron L.P. Berghmans; Guy A.M. Widdershoven; Frans R.J. Verhey 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

## Abstract ## Background The use of Cholinesterase inhibitors (ChE‐Is) has raised debate in the literature on the ethical issues of drug treatment in dementia patients. These issues concern the quality of life of dementia patients and the process of decision‐making regarding the use of ChE‐Is. We

Impact of the Food and Drug Administrati

Impact of the Food and Drug Administration’s antipsychotic black box warning on psychotropic drug prescribing in elderly patients with dementia in outpatient and office-based settings

✍ Vibha C.A. Desai; Pamela C. Heaton; Christina M.L. Kelton 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 211 KB

DU3 IMPACT OF THE FDA'S ANTIPSYCHOTIC BL

DU3 IMPACT OF THE FDA'S ANTIPSYCHOTIC BLACK BOX WARNING ON PSYCHOTROPIC DRUG PRESCRIBING IN ELDERLY PATIENTS WITH DEMENTIA IN OUTPATIENT AND OFFICE-BASED SETTINGS

✍ V.C. Desai; P.C. Heaton; C. Kelton 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

P105 Treatment options in patients with

P105 Treatment options in patients with metastatic castrate-resistant prostate cancer (mCRPC) previously treated with a docetaxel-containing regimen: A single UK cancer centre's experience using patients within the early access programme and cancer drugs fund

✍ Hague, C.J.; Kelly, C.L.S.; Cornthwaite, S.A.; Birtle, A.J. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 65 KB